VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2010

Jul 13, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2010-07-09

Reporting Person: Riley Wayne Joseph (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-07-09	Stock Options	$33.89	A	30000	Acquired	2020-07-08	Common Stock (30000)	Direct

Footnotes

F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years.